Feed aggregator

A new study reveals that ingestions of water beads by young children have surged in recent years. Researchers at the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children's Hospital and the Central Ohio Poison Center analyzed calls to U.S. poison centers and found an alarming 6,532% increase in the rate of reported water bead ingestions among children younger than 6 years from 2019 to 2023, followed by a 24% decrease from 2023 to 2024.

Immunotherapy has become a standard of care in treating high-risk, early-stage breast cancers, yet it has had limited success in shrinking tumors.

A new randomized clinical trial provides some of the clearest evidence to date that what we eat can meaningfully reshape both human health and the health of the planet.

The University of Texas at San Antonio (UT San Antonio) has been awarded a five-year, $44 million contract from the National Heart, Lung, and Blood Institute of the National Institutes of Health for a landmark study focused on persistent health challenges in the rural South.

For nearly 25 years, scientists believed they knew what caused the most severe form of narcolepsy. A new UCLA Health study now suggests they were only half correct.

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes the progressive loss of motor neurons, which in most cases leads to respiratory failure within three to five years after diagnosis.

Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could be targeted as a potential therapy.

The World Stroke Organization is warning that climate change poses an escalating threat to brain health, with extreme heat in particular increasing the risk of having a stroke and of patients dying from stroke.

When transplant surgeons switched between different organ types in consecutive surgeries, one-year mortality rates in patients increased by 14.8 percent, according to new Virginia Tech research.

Researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have uncovered a surprising link between low brain sugar levels and the development of myelin - the protective coating that allows nerve cells to communicate rapidly and efficiently.

Silencing a major cellular stress signal could be the key to a longer life, according to new University of Sheffield research.

Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.

Small abnormalities in blood sugar, blood lipids and inflammation several years before pregnancy are linked to an increased risk of high blood pressure during pregnancy and pre-eclampsia, according to a new study from Karolinska Institutet published in JAMA Network Open.

A deadly form of leukemia may be stopped before it ever develops by introducing targeted maternal screening in the United States, according to new research.

A new study is raising questions about whether human endurance has biological limits shaped long before adulthood-possibly beginning at birth.

A study supported by FAPESP shows that small doses of the antibiotic minocycline may help treat panic disorder.

HPV infections in women aged 27+ highlight the need for updated vaccination policies, emphasizing ongoing risk and the importance of preventive healthcare.

The use of mailed FIT-DNA kits in community health centers significantly increases colorectal cancer screening, though follow-up colonoscopy rates remain low.

Sapio Sciences, the AI lab informatics company, today announced that Claude Cowork, Anthropic's agentic AI assistant, is now integrated with the Sapio Platform via Sapio Elain, the AI co-scientist.

A review of 1,801 registered CAR T clinical trials shows that multifunctional designs now account for 533 trials and 33% of new CAR T products submitted for clinical testing in 2025. The field is shifting toward multitargeted, safety-controlled, cytokine-secreting, and checkpoint-modulating CAR T cells, but manufacturing, regulation, and limited clinical outcome data remain key barriers.